- Home
- SPH vs ELVN Comparison
SPH vs ELVN Comparison
Compare SPH & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPH | ELVN |
|---|---|---|
| Founded | 1945 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.8B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SPH | ELVN |
|---|---|---|
| Price | $20.42 | $30.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | 143.2K | ★ 573.1K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.42% | N/A |
| EPS Growth | ★ 42.11 | 3.17 |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $1,432,518,000.00 | N/A |
| Revenue This Year | $2.06 | N/A |
| Revenue Next Year | $1.64 | $40.06 |
| P/E Ratio | $29.45 | ★ N/A |
| Revenue Growth | ★ 7.94 | N/A |
| 52 Week Low | $17.30 | $13.30 |
| 52 Week High | $21.72 | $30.63 |
Technical Indicators
Market Signals| Indicator | SPH | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 63.95 |
| Support Level | $17.86 | $18.89 |
| Resistance Level | $20.59 | N/A |
| Average True Range (ATR) | 0.42 | 1.46 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 60.21 | 87.96 |
Price Performance
Historical ComparisonAbout SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.